ELMSFORD, N.Y.--(BUSINESS WIRE)--AFP Imaging Corporation (OTCBB: AFPC.OB) announced today that it has received 510K clearance from the U.S. Food and Drug Administration (FDA) to market the Company’s advanced NewTom™ VG Cone Beam Computed Tomography Scanner. This proprietary, dental imaging system provides the clinician with detailed three-dimensional, radiographic images of the teeth and jaws along with optimal patient comfort through flexible seating options. NewTom VG (“Vertical Generation”), patients can now stand, sit, or remain in their wheel chairs while being scanned. The unit’s smaller footprint makes it ideal for in-office examination procedures when space is limited in the operatory. The primary applications are for diagnosis and treatment planning for dental implants, orthodonture and oral surgery plus Ear Nose and Throat procedures.
